VDAC1 and Parkinson disease: In the brain of PD patients, VDAC1 could also increase the concentrations of Ca2+ in the mitochondria, leading to the increase of mitochondrial permeability, the disruption of mitochondrial membrane potential, and eventually to neuronal apoptosis and degeneration [116].